ArticlePloS one2025
Influence of inter-fractional respiratory motion changes on dose delivery accuracy in dynamic conformal arc lung stereotactic body radiotherapy: A phantom study.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the influence of inter-fractional respiratory motion variation on dose delivery accuracy in dynamic conformal arc lung stereotactic body radiotherapy (SBRT) using glass dosimeter and QUASARTM respiratory motion phantom. MATERIALS AND
methodsFour-dimensional computed tomography (4D-CT) was acquired using a sinusoidal respiratory waveform (amplitude: 10 mm, breaths per minute [BPM]: 20). Three glass dosimeters were positioned at the superior edge, geometric center, and inferior edge of the tumor target. Internal target volume (ITV)-SBRT and gated-SBRT plans were created and delivered under nine respiratory conditions (BPM: 10-30, amplitude: 5-30 mm). Treatment was considered acceptable if the delivered dose to the glass dosimeters remained within the D5%-D95% of the gross tumor volume.
resultsBPM had minimal effect on ITV-SBRT, with the doses delivered to the target remaining within the acceptable range for all BPMs. However, amplitude significantly affected SBRT accuracy. For ITV-SBRT, increase in amplitude caused underdose at both the superior and inferior edges. In gated-SBRT, higher amplitude led to significant underdosing at superior edge of the target than that observed in ITV-SBRT, while inferior edge remained within the acceptable dose range. Underdose worsened with increasing amplitude, and 10 mm increase from the reference caused it to fall below the acceptable range (D95%).
conclusionRespiratory motion significantly affects dose delivery accuracy in lung SBRT, with amplitude playing a critical role. An amplitude increase of ≥ 10 mm from CT acquisition during SBRT delivery resulted in a significant target underdosing below the clinically acceptable threshold.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.